Skip to main content
    O

    Omnicell Inc (OMCL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $35.44
    +0.41 (+1.17%)

    Market Cap: $1.61B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Omnicell Inc (OMCL) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Omnicell (OMCL) trades at 17.6x trailing earnings and 1.3x sales. Its P/E of 17.6x is below its 5-year median of 21.6x. Its forward P/E is 29.5x. The median P/E across 7 similar companies is 35.4x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 40.3% lower over the next year. PEG is left out because the growth rate behind it, P/E divided by PEG, is under 2% a year.

    MultipleValue
    P/E (trailing)17.6x
    Forward P/E29.5x
    Price to sales1.3x
    Price to book1.2x
    EV/EBITDA9.7x
    Price to FCF11.2x
    EV/FCF10.2x
    PEGN/A
    FCF yield9.0%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 38.7% below 28.7x, its P/S is 50.0% below 2.6x and its P/B is 63.6% below 3.3x.

    MultipleCurrent5-year median10-year median
    P/E17.6x21.6x28.7x
    P/S1.3x1.7x2.6x
    P/B1.2x1.6x3.3x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 16.8x in 2022 to 47.5x in 2021.

    Year endPriceP/EP/SP/B
    2025$45.3028.0x1.8x1.7x
    2024$44.5226.2x1.8x1.7x
    2023$37.6319.7x1.5x1.4x
    2022$50.4216.8x1.7x2.0x
    2021$180.4447.5x7.2x7.8x
    2020$120.0247.3x5.8x5.5x
    2019$81.7229.1x3.8x4.2x
    2018$61.2429.4x3.1x3.7x
    2017$48.5036.5x2.6x3.7x
    2016$33.9022.6x1.8x2.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OMCL

    What is OMCL's forward P/E ratio?

    Omnicell has a forward P/E ratio of 29.5x.

    Is OMCL stock overvalued?

    GNG's valuation label for OMCL is Undervalued. Its P/E of 17.6x compares with a median of 35.4x across 7 similar companies.

    What is OMCL's price to sales ratio?

    Omnicell has a price to sales ratio of 1.3x.

    What is Omnicell's average P/E ratio over 5 years?

    Omnicell's median P/E over the last 5 years is 21.6x, from 60 month-end values through Oct 2026.